{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:19:38Z","timestamp":1791991178477,"version":"4.4.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01157","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T05:01:45Z","timestamp":1591160505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice"],"prefix":"10.3389","volume":"11","author":[{"given":"Toni","family":"Weinhage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloys","family":"Lueken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris V.","family":"Skryabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Wittkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Foell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00134-006-0517-7","article-title":"Epidemiology of sepsis in Germany: results from a national prospective multicenter study","volume":"33","author":"Engel","year":"2007","journal-title":"Intensive Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research","volume":"19","author":"Rubio","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin","volume":"76","author":"Galanos","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1179\/096805104225004879","article-title":"D-galactosamine lethality model: scope and limitations","volume":"10","author":"Silverstein","year":"2004","journal-title":"J Endotoxin Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1164\/ajrccm.159.4.9712012","article-title":"LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock","volume":"159","author":"Mignon","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4049\/jimmunol.154.3.1307","article-title":"Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release","volume":"154","author":"Leist","year":"1995","journal-title":"J Immunol"},{"key":"B8","first-page":"1220","article-title":"Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models","volume":"146","author":"Leist","year":"1995","journal-title":"Am J Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. the soluble TNF receptor sepsis study Group","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/jama.271.23.1836","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/0140-6736(91)92725-H","article-title":"Production of interleukin-1-receptor antagonist during experimental endotoxaemia","volume":"338","author":"Granowitz","year":"1991","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1189\/jlb.1012519","article-title":"RAGE regulation and signaling in inflammation and beyond","volume":"94","author":"Kierdorf","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"B16","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am J Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/modpathol.3800450","article-title":"Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs","volume":"18","author":"Cheng","year":"2005","journal-title":"Mod Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/07853890902806576","article-title":"Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation","volume":"41","author":"Yan","year":"2009","journal-title":"Ann Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1111\/ajt.13360","article-title":"Hyperglycemia and liver ischemia reperfusion injury: a role for the advanced glycation endproduct and its receptor pathway","volume":"15","author":"Yue","year":"2015","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1196\/annals.1433.056","article-title":"Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis","volume":"1126","author":"Ramasamy","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"15256","DOI":"10.1038\/s41598-018-33661-y","article-title":"RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr(-\/-) mice","volume":"8","author":"Bijnen","year":"2018","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000328798","article-title":"The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration","volume":"4","author":"Berthelot","year":"2012","journal-title":"J Innate Immun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.178.4.2483","article-title":"Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium","volume":"178","author":"Zen","year":"2007","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2003-10-3536","article-title":"Regulation of monocyte migration by amphoterin (HMGB1)","volume":"104","author":"Rouhiainen","year":"2004","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0141000","DOI":"10.1371\/journal.pone.0141000","article-title":"Receptor for advanced glycation end products (RAGE) serves a protective role during klebsiella pneumoniae - induced pneumonia","volume":"11","author":"Achouiti","year":"2016","journal-title":"PLoS ONE"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/carcin\/bgn188","article-title":"RAGE, carboxylated glycans and S100A8\/A9 play essential roles in colitis-associated carcinogenesis","volume":"29","author":"Turovskaya","year":"2008","journal-title":"Carcinogenesis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/ncprheum0531","article-title":"Mechanisms of disease: a \u2018DAMP\u2019 view of inflammatory arthritis","volume":"3","author":"Foell","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1172\/JCI200418704","article-title":"Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response","volume":"113","author":"Liliensiek","year":"2004","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.4049\/jimmunol.1600197","article-title":"The receptor for advanced glycation endproducts drives T cell survival and inflammation in type 1 diabetes mellitus","volume":"197","author":"Durning","year":"2016","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.4049\/jimmunol.0801199","article-title":"The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia","volume":"182","author":"van Zoelen","year":"2009","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1086\/604730","article-title":"Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice","volume":"200","author":"van Zoelen","year":"2009","journal-title":"J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/QCO.0b013e3283519b82","article-title":"Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?","volume":"25","author":"Christaki","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2249.2008.03815.x","article-title":"Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained","volume":"155","author":"Blom","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmgh.2015.04.005","article-title":"Granulocyte macrophage colony-stimulating factor-activated CD39+\/CD73+ murine monocytes modulate intestinal inflammation via induction of regulatory T cells","volume":"1","author":"Weinhage","year":"2015","journal-title":"CMGH Cell Mol Gastroenterol Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"G823","DOI":"10.1152\/ajpgi.00115.2010","article-title":"The functional\u2212374T\/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease","volume":"300","author":"Dabritz","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/cc6164","article-title":"Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis","volume":"12","author":"Bopp","year":"2008","journal-title":"Crit Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cytogfr.2014.07.002","article-title":"Danger, diversity and priming in innate antiviral immunity","volume":"25","author":"Collins","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1097\/01.CCM.0000287588.69000.97","article-title":"Systemic and local high mobility group box 1 concentrations during severe infection","volume":"35","author":"van Zoelen","year":"2007","journal-title":"Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3389\/fimmu.2019.02536","article-title":"DAMPs and NETs in Sepsis","volume":"10","author":"Denning","year":"2019","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.4049\/jimmunol.174.12.8125","article-title":"Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition","volume":"174","author":"Zhang","year":"2005","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/cc6184","article-title":"Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection","volume":"11","author":"Lutterloh","year":"2007","journal-title":"Crit Care"},{"key":"B45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/SHK.0b013e31820b2e1c","article-title":"A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia","volume":"35","author":"Christaki","year":"2011","journal-title":"Shock"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","article-title":"Septic shock is associated with receptor for advanced glycation end products ligation of LPS","volume":"186","author":"Yamamoto","year":"2011","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","article-title":"Monocyte-mediated defense against microbial pathogens","volume":"26","author":"Serbina","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jhep.2013.12.005","article-title":"A TLR2\/S100A9\/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse","volume":"60","author":"Moles","year":"2014","journal-title":"J Hepatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1478-3231.2006.01327.x","article-title":"Role of neutrophils in acute inflammatory liver injury","volume":"26","author":"Jaeschke","year":"2006","journal-title":"Liver Int"},{"key":"B50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI76887","article-title":"The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis","volume":"125","author":"Huebener","year":"2015","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"C249","DOI":"10.1152\/ajpcell.00302.2011","article-title":"Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing","volume":"302","author":"Tadie","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/03602532.2011.602688","article-title":"Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity","volume":"44","author":"Jaeschke","year":"2012","journal-title":"Drug Metab Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BFb0027661","article-title":"Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death","volume":"71","author":"Decker","year":"1974","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"S637","DOI":"10.33549\/physiolres.933225","article-title":"The effect of D-galactosamine on lean and steatotic rat hepatocytes in primary culture","volume":"64","author":"Kucera","year":"2015","journal-title":"Physiol Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1423-0127-16-35","article-title":"Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling","volume":"16","author":"Lin","year":"2009","journal-title":"J Biomed Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0005-2760(85)90259-0","article-title":"Effect of D-galactosamine in vitro on [U-14C]palmitate oxidation, triacylglycerol synthesis and secretion in isolated hepatocytes","volume":"833","author":"Mangeney","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"B57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0021-9258(19)43113-X","article-title":"Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. effect on ribonucleic acid synthesis","volume":"249","author":"Keppler","year":"1974","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","first-page":"G322","DOI":"10.1152\/ajpgi.1997.273.2.G322","article-title":"Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion","volume":"273","author":"Rowell","year":"1997","journal-title":"Am J Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/srep00918","article-title":"Disparate roles of marrow- and parenchymal cell-derived TLR4 signaling in murine LPS-induced systemic inflammation","volume":"2","author":"Juskewitch","year":"2012","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajpath.2011.10.001","article-title":"LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels","volume":"180","author":"Juskewitch","year":"2012","journal-title":"Am J Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T21:38:33Z","timestamp":1696196313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2020.01157"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01157","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"article-number":"1157"}}